{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T08:45:14Z","timestamp":1772613914792,"version":"3.50.1"},"reference-count":36,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T00:00:00Z","timestamp":1765929600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Asia"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.jacasi.2025.11.018","type":"journal-article","created":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T19:29:28Z","timestamp":1772566168000},"page":"329-341","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Medication Adherence and Antithrombotic Therapy Outcomes"],"prefix":"10.1016","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-8568-8382","authenticated-orcid":false,"given":"Naoki","family":"Chiba","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Noda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kotaro","family":"Nochioka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichi","family":"Kaikita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2348-7646","authenticated-orcid":false,"given":"Masaharu","family":"Akao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junya","family":"Ako","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuya","family":"Matoba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masato","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsumi","family":"Miyauchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuhisa","family":"Hagiwara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuo","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kunihiko","family":"Matsui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hisao","family":"Ogawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Yasuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.jacasi.2025.11.018_bib1","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1056\/NEJMoa1904143","article-title":"Antithrombotic therapy for atrial fibrillation with stable coronary disease","volume":"381","author":"Yasuda","year":"2019","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.jacasi.2025.11.018_bib2","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","volume":"42","author":"Hindricks","year":"2021","journal-title":"Eur Heart J"},{"issue":"23","key":"10.1016\/j.jacasi.2025.11.018_bib3","doi-asserted-by":"crossref","first-page":"3028","DOI":"10.1161\/CIRCULATIONAHA.108.768986","article-title":"Medication adherence","volume":"119","author":"Ho","year":"2009","journal-title":"Circulation"},{"issue":"34","key":"10.1016\/j.jacasi.2025.11.018_bib4","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1093\/eurheartj\/ehab484","volume":"42","author":"Visseren","year":"2021","journal-title":"Eur Heart J"},{"issue":"8","key":"10.1016\/j.jacasi.2025.11.018_bib5","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.jacc.2022.04.065","article-title":"Impact of medication nonadherence in a clinical trial of dual antiplatelet therapy","volume":"80","author":"Valgimigli","year":"2022","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"10.1016\/j.jacasi.2025.11.018_bib6","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.jacc.2016.06.005","article-title":"Assessing the impact of medication adherence on long-term cardiovascular outcomes","volume":"68","author":"Bansilal","year":"2016","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.jacasi.2025.11.018_bib7","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.119.005969","article-title":"Real-world adherence and persistence to direct oral anticoagulants in patients with atrial fibrillation","volume":"13","author":"Ozaki","year":"2020","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"6","key":"10.1016\/j.jacasi.2025.11.018_bib8","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.17156","article-title":"Analysis of oral anticoagulant dosing and adherence to therapy among patients with nonvalvular atrial fibrillation","volume":"6","author":"Rymer","year":"2023","journal-title":"JAMA Netw Open"},{"issue":"1","key":"10.1016\/j.jacasi.2025.11.018_bib9","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1161\/STROKEAHA.117.018395","article-title":"Real-world use of apixaban for stroke prevention in atrial fibrillation","volume":"49","author":"Proietti","year":"2018","journal-title":"Stroke"},{"issue":"9","key":"10.1016\/j.jacasi.2025.11.018_bib10","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1177\/2047487317695628","article-title":"The impact of medication adherence on clinical outcomes of coronary artery disease: a meta-analysis","volume":"24","author":"Du","year":"2017","journal-title":"Eur J Prev Cardiol"},{"issue":"4","key":"10.1016\/j.jacasi.2025.11.018_bib11","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1093\/europace\/euz273","article-title":"The optimal drug adherence to maximize the efficacy and safety of non-vitamin K antagonist oral anticoagulant in real-world atrial fibrillation patients","volume":"22","author":"Kim","year":"2020","journal-title":"EP Europace"},{"issue":"1","key":"10.1016\/j.jacasi.2025.11.018_bib12","doi-asserted-by":"crossref","first-page":"3413","DOI":"10.1038\/s41598-022-07316-y","article-title":"Adherence is an optimal factor for maximizing the effective and safe use of oral anticoagulants in patients with atrial fibrillation","volume":"12","author":"Yang","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.jacasi.2025.11.018_bib13","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.ijcard.2018.04.131","article-title":"Atrial fibrillation and ischemic events with rivaroxaban in patients with stable coronary artery disease (AFIRE): protocol for a multicenter, prospective, randomized, open-label, parallel group study","volume":"265","author":"Yasuda","year":"2018","journal-title":"Int J Cardiol"},{"issue":"2","key":"10.1016\/j.jacasi.2025.11.018_bib14","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2018-000997","article-title":"Adherence to coronary artery disease secondary prevention medicines: exploring modifiable barriers","volume":"6","author":"Khatib","year":"2019","journal-title":"Open Heart"},{"issue":"3","key":"10.1016\/j.jacasi.2025.11.018_bib15","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.jjcc.2016.11.009","article-title":"Adherence to medication and characteristics of Japanese patients with non-valvular atrial fibrillation","volume":"70","author":"Suzuki","year":"2017","journal-title":"J Cardiol"},{"issue":"8","key":"10.1016\/j.jacasi.2025.11.018_bib16","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.jacc.2022.05.045","article-title":"Association of medication adherence with health outcomes in the ISCHEMIA trial","volume":"80","author":"Garcia","year":"2022","journal-title":"J Am Coll Cardiol"},{"issue":"21","key":"10.1016\/j.jacasi.2025.11.018_bib17","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.021601","article-title":"Long-term medication adherence trajectories to direct oral anticoagulants and clinical outcomes in patients with atrial fibrillation","volume":"10","author":"An","year":"2021","journal-title":"J Am Heart Assoc"},{"issue":"2","key":"10.1016\/j.jacasi.2025.11.018_bib18","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.21357","article-title":"Latent classes of adherence to oral anticoagulation therapy among patients with a new diagnosis of atrial fibrillation","volume":"3","author":"Chen","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"46","key":"10.1016\/j.jacasi.2025.11.018_bib19","doi-asserted-by":"crossref","first-page":"3267","DOI":"10.1093\/eurheartj\/ehu364","article-title":"Non-adherence to cardiovascular medications","volume":"35","author":"Kolandaivelu","year":"2014","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.jacasi.2025.11.018_bib20","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1186\/s12872-021-01969-9","article-title":"Chronic polytherapy after myocardial infarction: the trade-off between hospital and community-based providers in determining adherence to medication","volume":"21","author":"Di Martino","year":"2021","journal-title":"BMC Cardiovasc Disord"},{"issue":"2","key":"10.1016\/j.jacasi.2025.11.018_bib21","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.jjcc.2022.07.022","article-title":"Clinical characteristics and outcomes of Japanese atrial fibrillation patients with poor medication adherence: a sub-analysis of the GENERAL study","volume":"81","author":"Akao","year":"2023","journal-title":"J Cardiol"},{"issue":"1","key":"10.1016\/j.jacasi.2025.11.018_bib22","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1477-9560-11-11","article-title":"Laboratory assessment of rivaroxaban: a review","volume":"11","author":"Samama","year":"2013","journal-title":"Thromb J"},{"key":"10.1016\/j.jacasi.2025.11.018_bib23","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.amjcard.2021.03.024","article-title":"Cardiovascular outcomes according to polypharmacy and drug adherence in patients with atrial fibrillation on long-term anticoagulation (from the RE-LY trial)","volume":"149","author":"Millenaar","year":"2021","journal-title":"Am J Cardiol"},{"issue":"25","key":"10.1016\/j.jacasi.2025.11.018_bib24","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1093\/eurheartj\/ehy377","article-title":"Standardized classification and framework for reporting, interpreting, and analysing medication non-adherence in cardiovascular clinical trials: a consensus report from the Non-adherence Academic Research Consortium (NARC)","volume":"40","author":"Valgimigli","year":"2019","journal-title":"Eur Heart J"},{"issue":"5","key":"10.1016\/j.jacasi.2025.11.018_bib25","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1056\/NEJMra050100","article-title":"Adherence to medication","volume":"353","author":"Osterberg","year":"2005","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.jacasi.2025.11.018_bib26","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.jacc.2016.11.034","article-title":"Improving medication adherence in cardiometabolic disease: practical and regulatory implications","volume":"69","author":"Ferdinand","year":"2017","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.jacasi.2025.11.018_bib27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002584","article-title":"Fixed-dose combination antihypertensive medications, adherence, and clinical outcomes: a population-based retrospective cohort study","volume":"15","author":"Verma","year":"2018","journal-title":"PLoS Med"},{"issue":"8","key":"10.1016\/j.jacasi.2025.11.018_bib28","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1016\/S0149-2918(01)80109-0","article-title":"A systematic review of the associations between dose regimens and medication compliance","volume":"23","author":"Claxton","year":"2001","journal-title":"Clin Therapeut"},{"issue":"20","key":"10.1016\/j.jacasi.2025.11.018_bib29","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1016\/j.jacc.2014.08.021","article-title":"A polypill strategy to improve adherence","volume":"64","author":"Castellano","year":"2014","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"10.1016\/j.jacasi.2025.11.018_bib30","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1093\/europace\/euv421","article-title":"Real-world persistence and adherence to oral anticoagulation for stroke risk reduction in patients with atrial fibrillation","volume":"18","author":"Beyer-Westendorf","year":"2016","journal-title":"EP Europace"},{"issue":"1","key":"10.1016\/j.jacasi.2025.11.018_bib31","doi-asserted-by":"crossref","first-page":"59","DOI":"10.2133\/dmpk.DMPK-12-RG-034","article-title":"Model-based dose selection for phase III rivaroxaban study in Japanese patients with non-valvular atrial fibrillation","volume":"28","author":"Tanigawa","year":"2013","journal-title":"Drug Metab Pharmacokinet"},{"issue":"8","key":"10.1016\/j.jacasi.2025.11.018_bib32","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/j.jval.2020.03.016","article-title":"Identifying adherence patterns across multiple medications and their association with health outcomes in older community-dwelling adults with multimorbidity","volume":"23","author":"Walsh","year":"2020","journal-title":"Value Health"},{"key":"10.1016\/j.jacasi.2025.11.018_bib33","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.thromres.2021.11.003","article-title":"Long-term adherence to direct acting oral anticoagulants and the influence of health beliefs after switching from vitamin-K antagonists: findings from the Switching Study","volume":"208","author":"Bartoli-Abdou","year":"2021","journal-title":"Thrombos Res"},{"issue":"38","key":"10.1016\/j.jacasi.2025.11.018_bib34","doi-asserted-by":"crossref","first-page":"2940","DOI":"10.1093\/eurheartj\/eht295","article-title":"Adherence to cardiovascular therapy: a meta-analysis of prevalence and clinical consequences","volume":"34","author":"Chowdhury","year":"2013","journal-title":"Eur Heart J"},{"issue":"3","key":"10.1016\/j.jacasi.2025.11.018_bib35","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/bcp.12194","article-title":"What are validated self-report adherence scales really measuring? A systematic review","volume":"77","author":"Nguyen","year":"2014","journal-title":"Br J Clin Pharmacol"},{"issue":"16","key":"10.1016\/j.jacasi.2025.11.018_bib36","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1001\/archinte.167.16.1798","article-title":"Self-reported medication adherence and cardiovascular events in patients with stable coronary heart disease","volume":"167","author":"Gehi","year":"2007","journal-title":"Arch Intern Med"}],"container-title":["JACC: Asia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772374725007045?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772374725007045?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T19:29:32Z","timestamp":1772566172000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772374725007045"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S2772374725007045"],"URL":"https:\/\/doi.org\/10.1016\/j.jacasi.2025.11.018","relation":{},"ISSN":["2772-3747"],"issn-type":[{"value":"2772-3747","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Medication Adherence and Antithrombotic Therapy Outcomes","name":"articletitle","label":"Article Title"},{"value":"JACC: Asia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacasi.2025.11.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation.","name":"copyright","label":"Copyright"}]}}